• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 5th November 2013

Groundbreaking EQ-5D Project Launched in the United Arab Emirates

This project explores how existing valuation approaches can be adapted to the UAE culture. OHE’s Professor Nancy Devlin and Koonal Shah have been working on-site in Abu Dhabi to establish a new programme to measure and value health in the…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Workshop launches new EQ-5D project in the UAE

This project explores how existing valuation approaches can be adapted to the UAE culture.

OHE’s Professor Nancy Devlin and Koonal Shah have been working on-site in Abu Dhabi to establish a new programme to measure and value health in the United Arab Emirates (UAE).

 

Workshop launches new EQ-5D project in the UAE

Workshop launches new EQ-5D project in the UAE

OHE’s Professor Nancy Devlin and Koonal Shah have been working on-site in Abu Dhabi to establish a new programme to measure and value health in the United Arab Emirates (UAE). The project is being undertaken in collaboration with Dr Iain Blair, Iffat Elbarazi and Dr Selini Katsaiti from the United Arab Emirates University, and Dr Manny Papadimitropoulos from Eli Lilly & Company and the University of Toronto. Data collection is being undertaken by Ipsos Observer.

The effort is the first of its kind in the Middle East. While there is interest in using patient-reported outcome measures such as the EQ-5D in UAE health care systems, no research has been done to date on local preferences regarding health and quality of life and no local value sets for EQ-5D states have been developed.

The initial aim of the project is to establish the acceptability and feasibility in this culture of using methods such as time trade off (TTO) exercises and discrete choice experiments (DCE) to value health states. The TTO approach has been widely used in Europe, North and South America and Asia, but it is not clear whether or to what the extent such methods are culturally appropriate for Emirati nationals, an Arabic-speaking Muslim population. The project is intended to assess the acceptability of TTO to this population and to explore the influence of culture and religious beliefs, and the appropriateness of the expressions, used on how participants respond to TTO questions.

Specifically, the research will address:

  • How respondents differ in their preferences for quality of life and in attitudes towards death compared with populations in other countries
  • How easy or difficult respondents find the valuation tasks
  • How the methods might be adjusted to make them more suitable for use in the UAE.

Data collection for the initial phase is about to commence, following a three-day workshop, run jointly by OHE, academics from UAE University and Ipsos Observer, that trained the interview team. Face-to-face interviews will be conducted to collect both quantitative data on EQ-5D values and extensive qualitative data on respondents’ feedback on the questions.

Reports from the project will be published in 2014.

The project’s full title is “An Investigation of Health State Values in the United Arab Emirates”. It is funded by Eli Lilly & Company (Global Patient Outcomes & Real World Evidence) and the EuroQol Group. Ethics consent for the research has been granted by the Al Ain Medical District Human Research Ethics Committee.

For additional information, please contact Prof Nancy Devlin.  

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Spotlight on OHE

Related News

  • News
  • November 2021

Opportunity Cost in Health Care: a Favourite Research Topic for OHE

Read more
  • News
  • May 2020

OHE Awarded Independent Research Organisation (IRO) Status by UKRI

Read more
  • News
  • February 2019

OHE Response to Public Consultation on NICE Principles

Read more
  • News
  • December 2018

OHE Achievements in 2018

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!